Submit RFP/RFI
Submit RFP/RFI
Search
Submit RFP/RFI
Submit RFP/RFI
Search
Submit RFP/RFI
Submit RFP/RFI
Search

Development of circulating anti-HLA antibodies is associated with acute rejection: Interim Analysis of CTOT02

SA De Serres, BG Mfarrej, I Guleria, N Najafian, D Ikle, FG Vincenti WE Harmon, MH Sayegh, and A Chandraker.
Abstract presented at ASN Kidney Week, 2011.
CTOT
12/31/2010
Presentation

Related insights

The CRO Decoder: What Site-Centric Really Means (And What it Doesn’t)

Every CRO out there will tell you they’re site-centric, and on pitch decks, they use the right

Read More
Blog
The Lean Team Playbook: How small biotechs can nail ICH E6(R3) without a large QA team

You’re responsible for showing risk oversight, protocol clarity, and a site-friendly design—but you’ve got a lean team,

Read More
Blog
The R3 Timewarp Redemption: Preventable risks and how to avoid them in a trial

Picture this: a complex trial is running, but it has been plagued with issues from the start.

Read More
Guides
The MythBusters Revelations: Debunking compliance myths to keep your trial on track

ICH E6(R3) is here, and with it, clinical teams are bracing for the impacts. Biotechs are being

Read More
Blog
The Site Cohesion Hypothesis: 3 examples of the impact of CRO site relationships

Behind every enrollment milestone is a web of relationships—some strong, some strained, and some that make all

Read More
Case Study
The Site Stickiness Hypothesis: Good site relationships pay dividends

Every CRO claims to value sites. But the true nature of their site relationships could determine the

Read More
Guides
Scroll to Top